Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	2.04	846.36	829.43
Graham Fair Price	-36.96	3567.77	5659.14
PEG	453.33	10.57	1.91
Price/Book	-18.32	4.85	5.94
Price/Cash Flow	-468.29	-496.13	-87.30
Prices/Earnings	-102.35	-633.86	-313.25
Price/Sales	-19.39	19.38	24.04
Price/FCF	-468.29	-496.13	-87.30
Naive Interpretation	member

01 - Valuation · Bad

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-6.52	0.04	0.04
Operating Margin	-37.95	-0.03	-0.02
ROA	61.96	< 0.005	< 0.005
ROE	< 0.005	< 0.005	59.64
ROIC	< 0.005	< 0.005	-329.07
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.14	-0.01	1109.51
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-2.01	-0.39	80.78
EPS QOQ	-1.64	0.60	-63.43
FCF QOQ	-2.39	0.86	-64.17
Revenue QOQ	-0.06	< 0.005	-91.08
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	124.01	128.37	3.51
Days Sales Outstanding (DSO)	59.75	58.16	-2.66
Inventory Turnover	0.73	0.70	-3.39
Debt/Capitalization	0.31	0.34	9.68
Quick Ratio	1.09	1.12	2.80
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	17332.12	17198.81	-0.77
Cash	4125.46	4923.59	19.35
Capex	-725.18	-622.13	14.21
Free Cash Flow	-1178.67	-168.10	85.74
Revenue	4280.30	4303.91	0.55
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	2.02	2.03	0.21
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	27.74	58.41	110.55
Naive Interpretation	Member

06 - Financial Health · Bad

Rating